In experiments to ascertain the biochemical basis of a genetically determined deficiency of the third component of complement (C3) in guinea pigs, we found that C3-deficient liver and peritoneal macrophages contain C3 messenger RNA of normal size (-5 kb) and amounts, that this mRNA programs synthesis of pro-C3 in oocytes primed with liver RNA and in primary macrophage cultures. In each instance, heterodimeric native C3 protein was secreted with normal kinetics but the C3 protein product of the deficient cells failed to undergo autolytic cleavage and was unusually susceptible to proteolysis. These data and a selective failure of C3 in plasma of deficient animals to incorporate 1"4Cjmethylamine suggested either a mutation in primary structure of the C3 protein or a selective defect in coor postsynthetic processing affecting the thiolester bridge, a structure important for C3 function. A mutation in the primary structure of C3 was ruled out by comparison of direct sequence analysis of C3 cDNA generated from two C3 deficient and two C3 sufficient guinea pig liver libraries. Three base pair differences, none resulting in derived amino acid sequence differences were identified. Finally, restriction fragment length polymorphisms were identified in the C3 gene that are independent of the deficiency phenotype. This marker of the C3 gene permits testing of these hypotheses using molecular biological and classical genetic methods. (J. Clin. Invest. 1990. 86:96-106.)
Introduction
The importance of the complement (C)' system in host defenses and immunopathology has been fully appreciated in the study of congenital and acquired complement deficiencies. The third component ofcomplement (C3) in particular plays a pivotal role in many facets of the inflammatory response. Alper et al. (1, 2) first described homozygous deficiency of C3 in a child with a history of recurrent infections. The principal pathogens affecting this child, as in most C3-deficient individuals (3) (4) (5) (6) , were encapsulated bacteria, thus helping to establish in vivo the importance of C3 in opsonization, phagocytosis, and intracellular killing of these organisms. However, subsequent reports of C3-deficient individuals have presented conflicting data on defects in other C3-dependent functions such as immune adherence, development of leukocytosis in response to infection, vasopermeability, and antibody response (1-1 1). One possible explanation for these conflicting data is that, in C3 deficient individuals, C3 is synthesized and secreted, albeit at markedly reduced rates. Some C3 functions might therefore be retained, especially in extravascular sites. This suggestion is supported by observations that monocytes isolated from individuals with < 0.01% normal serum levels of C3, produced C3 at a rate -25% of normal (12) . Thus, although the hepatocyte is the primary source of plasma C3, studies of C3 biosynthesis in monocytes, fibroblasts and synovial tissue from patients with rheumatoid arthritis (13) suggested that regulation of C3 synthesis is independent in hepatocytes and other cells in extrahepatic sites. Ethical considerations and other technical constraints, however, did not permit further exploration of these questions in C3-deficient
humans.
An isolated genetically determined deficiency of C3 in the guinea pig has recently been described (14) . These animals were derived from an inbred strain 2 colony. Sera from C3 deficient (C3D) guinea pigs contain 5% of normal C3 as assessed functionally and antigenically, i.e., the C3 appeared to have approximately normal specific hemolytic activity. Preliminary studies (14) suggested that peritoneal macrophages and hepatocytes from the C3D animals produced normal amounts ofC3 and studies ofthe clearance of 1251I-radiolabeled normal guinea pig C3 in C3D guinea pigs demonstrated a normal catabolic rate. It is interesting that C3-deficient guinea pigs mounted only a minimal primary antibody response to X X 174, a T cell-dependent antigen, and failed to undergo isotype switching from IgM to IgG with booster immunizations (15) . This inadequate antibody response has also been found in deficiencies of complement components of the classical pathway (16, 17) ; all are believed to be due to deficiency of activated C3.
The availability of a small animal model deficient in C3 prompted further studies of the molecular basis for C3 deficiency. In this report we show that cells from C3D animals express C3 mRNA similar in size and amount to that found in normal cells. 
Methods
[IC X C XC N C3D Antibodies. Antiserum to guinea pig C4 was raised in C4-deficient guinea pigs (19) by previously described methods (18) . Antiserum to guinea pig C3 was raised in albino rabbits by subcutaneous injection of 1.0 ml of a mixture containing equal volumes of purified guinea pig C3, 1.0 mg/ml (supplied by M. Thomas 10 mM Tris, 5 mM EDTA, 50 mM e-aminocaproic acid, 0.2% Na azide, 0.2 mM PMSF, 100 mM NaCl, pH 7.4. 2 ml of normal or C3D guinea pig serum was applied and eluted with a 20-ml gradient to 500 mM NaCl in the same buffer. -ml fractions were collected. RNA. Total liver RNA was isolated from three C3-sufficient (Hartley, one animal, C4-deficient subline ofNIH multipurpose guinea pigs, two animals) and two C3-deficient guinea pig livers according to previously described techniques (21) . The polyadenylated RNA fraction was isolated by affinity chromatography on oligo-dT cellulose (22) .
Construction of cDNA libraries. The C4-and C3-deficient poly A' was used to direct cDNA synthesis, which was then cloned into lambda ZAP by a modification of the methods described by Okayama and Berg (23, 24) . Oligo-dT (12) (13) (14) (15) (16) (17) (18) or specific oligonucleotides designed from the guinea pig C3 sequence were utilized as primers for first strand synthesis in generating the primer extension libraries from one additional C3-sufficient (C4 deficient) and C3-deficient animal. (Fig. 2) .
The size and subunit composition of the C3D and normal guinea pig liver-derived native C3 were similar, but again the 70-and 48-kD products were only visualized when the oocytes were injected with normal mRNA (even overexposed gels failed to demonstrate 70-and 48-kD products in C3D-injected oocytes [data not stown]). Immunoprecipitation of C4, a complement protein homologous with C3, from the normal and C3D cultures (Fig. 3) revealed comparable amounts of pro-C4 intracellularly and native C4 in the extracellular medium. Secretion of C3. To ascertain the rates of C3 secretion in normal and C3-deficient cells, peritoneal cell cultures were pulse labeled for 30 min with [35S]methionine (500 MCi/ml), washed, and refed with medium containing unlabeled methionine. Cell lysates and media were then assayed for radiolabeled C3 protein (Fig. 4) . These data showed that the kinetics of C3 secretion and net recovery of C3 protein were similar in the C3D and normal peritoneal cells.
Autolytic cleavage and thiolester bridge. Since the 70-and 48-kD polypeptides precipitable with antisera to C3 observed in Fig. 1 are similar in size to the previously reported C3 autolytic cleavage products, we attempted to generate these fragments from 35S-labeled native C3 protein produced in C3D and normal peritoneal cell cultures by incubating the media in dilute alkaline SDS at 75°C for 20 min (21, 26) . Again (Fig. 5) , the 70-and 48-kD bands were visualized only in the normal but not in the C3D-derived culture media.
Methylamine incorporation into plasma C3, C4, and a2 macroglobulin. Previous reports have shown that C3D guinea pig plasma contains C3 both functionally and antigenically at around 5% of the level found in normals. To examine the possibility that residual C3 in plasma from C3D guinea pigs differed from that produced in tissue culture the following experiment was performed. Plasma from C3D and normal guinea pigs were fractionated on an ion exchange column and aliquots of each fraction examined for the ability to incorporate '4C-labeled methylamine, a function ofan intact thiolester bridge. Fig. 6 demonstrates that methylamine was incorporated into a2-macroglobulin and C4, two proteins that contain thiolester bonds, in both normal and C3D plasma; methylamine incorporation into C3 was detected only in normal but not C3D plasma even when the C3D plasma fractions were concentrated -20-fold (data not shown) to account for the difference in content of C3 in'the deficient plasma.
Proteolysis. Trypsin cleavage of native C3 protein produced by normal guinea pig peritoneal cells resulted in generation of C3b, as expected (Fig. 7) . However, incubation of the C3D-derived native C3 protein with between 0.01 and 0.1 g of trypsin (10-fold less than the minimal concentration required for C3b generation from normal C3) resulted in complete loss of immunoprecipitable C3 protein.
C3 transcription. As shown in Fig. 8 , Northern blot analysis of total RNA isolated from C3D and C3 sufficient guinea pigs revealed mature C3 mRNA transcripts (-5 kb) comparable in size and amount. That is, C3 mRNA from normal and C3D guinea pig liver appeared qualitatively and quantitatively indistinguishable. The ethidium-stained gel indicated that comparable amounts of RNA were analyzed.
C3 gene structure. DNA was isolated from Hartley, C2-deficient (strain 13), C4-deficient (strain 13), and C3-deficient (strain 2) animals, digested with several restriction enzymes (Pst I, Eco RI, Bam HI, Hind III, Bgl I, and Sma I) and subjected to Southern blot analysis (27) using a full length normal guinea pig C3 cDNA probe. Fig. 9 shows that digestion with either Pst I or Eco RI resulted in restriction fragment length polymorphisms (additional 2.3 kb [Pst I] and 1.6 kb fEco RI] bands) in the C3D and C4D samples. Since C3 protein synthesis and C3 serum concentrations are normal in C4-deficient guinea pigs, this polymorphism is not a marker for the C3 deficiency phenotype.
Comparison of C3 cDNA from C3-sufficient and deficient liver libraries. 17 C3 clones from the C3-deficient library and 25 clones from the C4-deficient library were detected; the largest insert, 3.8 kb in the C3-deficient and 4.2 kb in the C4-deficient libraries. Inserts from the three largest clones of each library were isolated and sequenced. As shown in Fig. 10 , 70% of the cDNA was analyzed using this sequencing strategy, with most regions sequenced several times on both strands. To complete the sequence, oligonucleotides were constructed and used as primers for dideoxy sequencing directly from phagemids. Using this initial strategy, the C3 cDNA sequence extended from the poly(A) tail through the 750 and 1150 most 5' nucleotides of the ,B chain for C3-deficient and C3-sufficient clones, respectively.
To complete the C3 cDNA sequence, primer extension cDNA libraries were constructed using a C3 specific oligonucleotide (20 mer) corresponding to positions 2469-2488 of complete guinea pig C3 cDNA sequence. Clones isolated from each library contained sequences that extended 29 nucleotides 5' of the C3 signal peptide and overlapped by 1312 and 1712 nucleotides, the largest clones from the C3-deficient and C3-sufficient libraries. Confirmation of the normal and C3 deficient guinea pig C3 sequence was accomplished by direct sequence analysis of PCR fragments generated from C3 sufficient (Hartley) and C3 deficient mRNA (Fig. 10) .
The complete C3-sufficient (C4 deficient) guinea pig C3 cDNA sequence and derived amino acid sequence are shown in Fig. 1 1. The sequence spans 5081 nucleotides, from 29 base pairs upstream of the signal peptide to the beginning of the poly(A) tail. A putative polyadenylation signal, AATAAA, is located 16 nucleotides upstream from the polyadenylation site, and is identical to the polyadenylation signal described for murine C3 and Slp. The deduced C3 protein sequence consists of 1666 amino acids in a (3-a chain orientation with four arginines interposed between the # and a chains. The coding region is, therefore, equal in size to murine C3 and three amino acid residues longer than human C3. Overall, 77-80% nucleotide and amino acid identity was observed for human, mouse, and guinea pig C3. Complete nucleotide identity between human and guinea pig C3 sequences was found at the thiolester 1 5-base pair segment within the flanking 45 base pairs in each direction. Guinea pig C3 shares other structural and functional characteristics with human and murine C3, including two asparagine carbohydrate attachment sites at positions 944 and 1620, a trypsin cleavage site between lysine at position 1006 and histidine at 1007, and two Factor I cleavage sites at positions 1310 and 1327.
C3-sufficient (C4 deficient) and C3-deficient guinea pig C3 cDNA sequences were compared. Only three nucleotide differences, at positions 83, 1630, and 2789 were found (Fig. 10) . These nucleotide differences are "silent" in that they do not result in a difference in the derived amino acid sequences. The sequence of PCR fragments from an additional C3-deficient liver mRNA was identical to the sequence generated from the C3-deficient cDNA and primary extension libraries. The Hartley C3 PCR fragments showed identity with the other C3-sufficient (C4 deficient) C3 cDNA sequence except at positions 83 (T to C); i.e., a substitution identical at this position with the C3-deficient sequence.
Discussion
Several possible explanations were considered to account for discrepancies between serum concentration of C3 and rate of C3 biosynthesis in previous studies of humans with genetically determined C3 deficiency (1-11). However, those experiments necessarily monitored C3 biosynthesis only at an extrahepatic site (blood monocytes) since ethical considerations precluded a direct test ofthe hypothesis that C3 synthesis rate in liver was more closely related to the deficiency than C3 synthesis in other tissues. One possibility that was not considered at that time was that a defective C3 protein susceptible to accelerated catabolism was produced by the deficient cells even though the newly synthesized C3 protein appeared grossly normal by estimates of size and subunit composition. Moreover, a near normal rate of catabolism of normal purified radiolabeled C3 protein was observed in a C3-deficient patient (3). Similar findings were obtained in the initial studies ofC3 catabolism in C3-deficient guinea pigs (14) . Preliminary data from those studies also suggested that C3 synthesis is normal in C3-deficient guinea pig hepatocytes.
In the present report we established that liver and peritoneal cells from C3-deficient, normal, and C4-deficient guinea pigs (a) contain C3 specific mRNA indistinguishable in size and quantity by Northern blot analysis, and (b) synthesize pro-C3 and secrete native C3 protein at similar rates. Although the C3 protein produced by the C3D peritoneal cells or secreted by oocytes primed with C3D liver mRNA appears normal in size and subunit composition it differs from normal C3 in at least two respects. That is, the C3D-derived C3 protein fails to undergo autolytic cleavage and is unusually susceptible to proteolytic digestion.
C3, C4, and a2 macroglobulin are proteins that share an unusual structural feature, a thiolester bridge, important in their respective functions. The phenomenon ofautolytic cleavage in dilute alkaline SDS is associated with the presence ofan intact thiolester bridge. The C3 protein produced in C3-deficient guinea pigs, by this criterion, appears to display a defect in the thiolester bridge or its accessibility. Support for this concept and for the selectivity of the defect is provided by demonstrating incorporation of methylamine into C4 and a2 macroglobulin, but not into C3 of C3 deficient plasma even when the samples are concentrated -20-fold to increase the C3 content in the C3D sample to near normal levels. An abnormality in primary or higher order structure of the C3-deficient C3 protein is also suggested by the unusual susceptibility of this protein to proteolysis. The rate of in vivo catabolism of this abnormal C3 protein is unknown because previous estimates of C3 metabolism in the deficient animals as in studies of C3D humans were obtained using normal purified radiolabeled C3 protein (14) .
These data are consistent with (a) a mutation in the coding region of the C3 gene leading to a defect in primary or higher order structure affecting the thiolester bridge or its accessibility, (b) a C3 specific co-or post-translational processing defect that affects the thiolester bridge; i.e., a genetic defect unlinked to the C3 gene. The finding of a restriction fragment length polymorphism (RFLP) that does not correlate with the C3 deficiency phenotype lends support to the latter hypothesis. That is, the RFLP provides a marker for the C3 structural gene distinct from the deficiency phenotype. Sequence analysis of C3 cDNA from C3 deficient guinea pig liver libraries ruled out a mutation in primary structure of the C3 gene as the basis for this genetic defect.
Sequencing of C3 cDNA clones from two separate C3 deficient liver libraries and from PCR fragments generated from a third C3-deficient liver mRNA preparation established that the C3 coding regions in C3-sufficient and deficient guinea pigs is identical except for positions 83, 1630, and 2789. None of these substitutions result in an amino acid difference. At position 83 the Hartley (C3 sufficient) sequence is identical to the C3-deficient sequence. These data thus support the hypothesis that C3 deficiency in guinea pig is due to a co-or postsynthetic processing modification that renders the C3 protein highly susceptible to proteolysis.
The biochemical mechanism by which the thiolester bridge is generated in C3 is uncertain. Kahn and Erickson (28) suggested that isomerization of a lactam ring to generate the thiolactone proceeds spontaneously under physiological conditions, though they could not rule out an enzymatically facilitated process. lijima et al. (29) on the other hand provided tentative evidence for participation of a cytoplasmic factor (possibly an enzyme) in the formation of the C3 thiolester. Heretofore, investigators have assumed but not tested the assumption that the mechanisms for generation of the C3, C4 and a2 macroglobulin thiolesters are identical. Since the mutation accounting for C3 deficiency is not in the coding region ofthe C3 gene, this defect provides a probe to examine co-and postsynthetic processing of this important group of proteins. Molecular biological and classical genetic studies are underway to test this hypothesis.
